These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7474323)

  • 21. [Activity of fosfomycin against Escherichia coli O157:H7--morphological changes and production of Shiga toxins].
    Takata T; Tabata M; Tsuruoka T; Watabe H
    Jpn J Antibiot; 2003 Dec; 56(6):691-6. PubMed ID: 15007877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fundamental and clinical studies on cefminox in the field of pediatrics].
    Arai S; Kawai K; Shimizu S; Kawamura Y; Kamiya H; Sakurai M
    Jpn J Antibiot; 1985 Mar; 38(3):720-9. PubMed ID: 3897605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Laboratory and clinical studies on cefminox in the pediatric field].
    Hosoda T; Ichioka T; Ito M; Sekiguchi T; Miyao M
    Jpn J Antibiot; 1985 Mar; 38(3):766-72. PubMed ID: 3897607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of lytic effect of beta lactams on Escherichia coli and other bacteria.
    Goodell EW; Lopez R; Tomasz A
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3293-7. PubMed ID: 9642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of cefminox in pediatric field].
    Ichihara K; Ueda S; Nakashima T; Miyachi Y; Yafuso M; Kuno K
    Jpn J Antibiot; 1985 Mar; 38(3):693-704. PubMed ID: 3897603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental and clinical evaluation of T-1982 (cefbuperazone) in the field of obstetrics and gynecology].
    Ninomiya K; Makino S; Hasegawa Y; Yoshimoto T
    Jpn J Antibiot; 1983 May; 36(5):986-93. PubMed ID: 6352989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus.
    Yokota T; Yoshida R; Utsui Y; Tajima M
    Drugs Exp Clin Res; 1985; 11(1):29-38. PubMed ID: 3915273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ampicillin-induced bacteriolysis of Escherichia coli is not affected by reduction in levels of anionic phospholipids.
    Rodionov DG; Ishiguro EE
    FEMS Microbiol Lett; 1997 Nov; 156(1):85-9. PubMed ID: 9368364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of inoculum size on bacteriolytic activity of cefminox and four other beta-lactam antibiotics against Escherichia coli.
    Soriano F; Edwards R; Greenwood D
    Antimicrob Agents Chemother; 1992 Jan; 36(1):223-6. PubMed ID: 1590693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Basic study on efficacy of cefmetazole against osseous and articular infections (author's transl)].
    Kawashima M; Tamura H; Kitahara Y; Jinyama K
    Jpn J Antibiot; 1982 Mar; 35(3):835-9. PubMed ID: 6954290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Susceptibility of clinically isolated Haemophilus influenzae to cephamycin antibiotics].
    Deguchi K
    Jpn J Antibiot; 1983 May; 36(5):1103-8. PubMed ID: 6604823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria].
    Kuga A; Yano H; Okamoto R; Sato Y; Miyata A; Inoue M
    Jpn J Antibiot; 1999 Sep; 52(9):585-94. PubMed ID: 10746193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A nationwide study of the antimicrobial susceptibility of clinical isolates of Klebsiella sp. in Japan].
    Igari J; Shitara M; Morimoto M; Shiga N; Kosakai N
    Jpn J Antibiot; 1986 Nov; 39(11):3110-24. PubMed ID: 3469423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of cefminox, a new cephamycin antibiotic, in the pediatric infections].
    Ohnari S; Meguro H; Nonaka C; Tajima T; Takahashi S; Fujii R
    Jpn J Antibiot; 1985 Mar; 38(3):671-8. PubMed ID: 3928938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics and antimicrobial effect of cefminox in serum and ascitic fluid for experimental purulent peritonitis in mice].
    Azuma Y; Tanimura H; Aoki Y; Isii T; Goi H
    Nihon Geka Hokan; 1989 Sep; 58(5):445-51. PubMed ID: 2701930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bactericidal effects and combined action of micronomicin with beta-lactam antibiotics against Pseudomonas aeruginosa and Escherichia coli].
    Yamashita K; Minagawa H; Sato K; Kitaura K; Okachi R
    Jpn J Antibiot; 1983 Jan; 36(1):189-93. PubMed ID: 6221129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of cefminox, a new bactericidal cephamycin.
    Watanabe S; Omoto S
    Drugs Exp Clin Res; 1990; 16(9):461-7. PubMed ID: 2100248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.